Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Top Cited Papers
- 15 June 2004
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (12) , 2328-2335
- https://doi.org/10.1200/jco.2004.04.033
Abstract
Purpose To estimate the risk of contralateral breast cancer in BRCA1 and BRCA2 carriers after diagnosis and to determine which factors are predictive of the risk of a second primary breast cancer. ...Keywords
This publication has 13 references indexed in Scilit:
- Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2MutationsNew England Journal of Medicine, 2002
- Outcome of conservatively managed early-onset breast cancer by BRCA1/2 statusThe Lancet, 2002
- Germline BRCA1/2 Mutations and p27Kip1 Protein Levels Independently Predict Outcome After Breast CancerJournal of Clinical Oncology, 2000
- Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control studyThe Lancet, 2000
- Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 MutationsJournal of Clinical Oncology, 2000
- Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancerBritish Journal of Cancer, 2000
- Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation CarriersJNCI Journal of the National Cancer Institute, 1999
- BRCA-associated breast cancer in young women.Journal of Clinical Oncology, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1The Lancet, 1998